92
- Slater CA, Davis RB, Shmerling RH. Antinuclear antibody testing. A study of clinical utility.
Arch Intern Med. 1996;156(13):1421–5. - Pincus T. A pragmatic approach to cost-effective use of laboratory tests and imaging proce-
dures in patients with musculoskeletal symptoms. Prim Care. 1993;20(4):795–814. - Pincus T, Sokka T. Laboratory tests to assess patients with rheumatoid arthritis: advantages
and limitations. Rheum Dis Clin North Am. 2009;35(4):731–4. vi–vii. - Pincus T, Schur PH, Rose JA, Decker JL, Talal N. Measurement of serum DNA-binding
activity in systemic lupus erythematosus. N Engl J Med. 1969;281(13):701–5. - Pincus T, Gibson KA, Shmerling RH. An evidence-based approach to laboratory tests in
usual care of patients with rheumatoid arthritis. Clin Exp Rheumatol. 2014;32(5 Suppl
85):S-23–8. - Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease—an
apparently distinct rheumatic disease syndrome associated with a specifi c antibody to an
extractable nuclear antigen (ENA). Am J Med. 1972;52(2):148–59. - Munves EF, Schur PH. Antibodies to Sm and RNP. Prognosticators of disease involvement.
Arthritis Rheum. 1983;26(7):848–53. - Nimelstein SH, Brody S, McShane D, Holman HR. Mixed connective tissue disease: a sub-
sequent evaluation of the original 25 patients. Medicine. 1980;59(4):239–48. - van der Heijde D, Landewe R, Klareskog L, Rodriguez-Valverde V, Settas L, Pedersen R,
et al. Presentation and analysis of data on radiographic outcome in clinical trials: experience
from the tempo study. Arthritis Rheum. 2005;52(1):49–60. - Pincus T. Assessment of long-term outcomes of rheumatoid arthritis. How choices of mea-
sures and study designs may lead to apparently different conclusions. Rheum Dis Clin North
Am. 1995;21(3):619–54. - Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis.
Arthritis Rheum. 1980;23(2):137–45. - Pincus T, Swearingen C, Wolfe F. Toward a multidimensional health assessment question-
naire (MDHAQ): assessment of advanced activities of daily living and psychological status
in the patient-friendly health assessment questionnaire format. Arthritis Rheum.
1999;42(10):2220–30. - Pincus T, Sokka T, Kautiainen H. Further development of a physical function scale on a
MDHAQ [corrected] for standard care of patients with rheumatic diseases. J Rheumatol.
2005;32(8):1432–9. - Wolfe F, Michaud K, Pincus T. Development and validation of the health assessment ques-
tionnaire ii: a revised version of the health assessment questionnaire. Arthritis Rheum.
2004;50(10):3296–305. - Anderson J, Caplan L, Yazdany J, Robbins ML, Neogi T, Michaud K, et al. Rheumatoid
arthritis disease activity measures: American college of rheumatology recommendations for
use in clinical practice. Arthritis Care Res. 2012;64(5):640–7. - Goldsmith CH, Smythe HA, Helewa A. Interpretation and power of a pooled index.
J Rheumatol. 1993;20(3):575–8. - Smith T. Questions on clinical trials. Br Med J. 1983;287(6392):569.
- Pincus T, Wolfe F. Patient questionnaires for clinical research and improved standard patient
care: is it better to have 80% of the information in 100% of patients or 100% of the informa-
tion in 5% of patients? J Rheumatol. 2005;32(4):575–7. - Meenan RF, Gertman PM, Mason JH. Measuring health status in arthritis. The arthritis
impact measurement scales. Arthritis Rheum. 1980;23(2):146–52. - Pincus T, Yazici Y, Bergman M, Maclean R, Harrington T. A proposed continuous quality
improvement approach to assessment and management of patients with rheumatoid arthritis
without formal joint counts, based on quantitative routine assessment of patient index data
(RAPID) scores on a multidimensional health assessment questionnaire (MDHAQ). Best
Pract Res Clin Rheumatol. 2007;21(4):789–804.
T. Pincus et al.